Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
FEBS Letters
|
May 23, 1998
Maize polyamine oxidase: primary structure from protein and cDNA sequencing
P Tavladoraki, M E Schininà, F Cecconi, et al.
Scientific Reports
|
November 22, 2019
The NATO project: nanoparticle-based countermeasures for microgravity-induced osteoporosis
F Cristofaro, G Pani, B Pascucci, et al.
Clinical Radiology
|
March 1, 2022
Cystic lung diseases: radiological aspects
T Valente, S Guarino, G Lassandro, et al.
Breast Cancer Research : BCR
|
April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
Claudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Anxiety, Stress, and Coping
|
November 14, 2007
Forgiving the September 11th terrorists: associations with coping, psychological distress, and religiosity
Galena Kline Rhoades, Daniel N McIntosh, Martha E Wadsworth, et al.
Nanoscale
|
November 2, 2017
Heterogeneous and self-organizing mineralization of bone matrix promoted by hydroxyapatite nanoparticles
G Campi, F Cristofaro, G Pani, et al.
Frontiers in Oncology
|
January 12, 2019
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Francesco Schettini, Irene De Santo, Carmen G Rea, et al.
Molecular and Clinical Oncology
|
April 8, 2020
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
Francesco Schettini, Irene De Santo, Carmen G Rea, et al.
Therapeutic Advances in Medical Oncology
|
December 18, 2020
Antitumor activity and efficacy of shorter <i>versus</i> longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis
Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
FEBS Letters
|
May 23, 1998
Maize polyamine oxidase: primary structure from protein and cDNA sequencing
P Tavladoraki, M E Schininà, F Cecconi, et al.
Scientific Reports
|
November 22, 2019
The NATO project: nanoparticle-based countermeasures for microgravity-induced osteoporosis
F Cristofaro, G Pani, B Pascucci, et al.
Clinical Radiology
|
March 1, 2022
Cystic lung diseases: radiological aspects
T Valente, S Guarino, G Lassandro, et al.
Breast Cancer Research : BCR
|
April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
Claudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Anxiety, Stress, and Coping
|
November 14, 2007
Forgiving the September 11th terrorists: associations with coping, psychological distress, and religiosity
Galena Kline Rhoades, Daniel N McIntosh, Martha E Wadsworth, et al.
Nanoscale
|
November 2, 2017
Heterogeneous and self-organizing mineralization of bone matrix promoted by hydroxyapatite nanoparticles
G Campi, F Cristofaro, G Pani, et al.
Frontiers in Oncology
|
January 12, 2019
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Francesco Schettini, Irene De Santo, Carmen G Rea, et al.
Molecular and Clinical Oncology
|
April 8, 2020
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
Francesco Schettini, Irene De Santo, Carmen G Rea, et al.
Therapeutic Advances in Medical Oncology
|
December 18, 2020
Antitumor activity and efficacy of shorter <i>versus</i> longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis
Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Page
of 6